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1. Purpose
Oxygen tension (pO ) performs a very important role in the appropriate working of tissues and organs2
as well as in the correct developing of an organism (1). It has been seen that a low oxygen
concentration has a fundamental role in the evolution of different pathologies situations like tumors,
strokes, isquemias, etc. On the other hand, tumors are heterogeneous respect their oxygenation level
and there is also a big variability of pO  at intratumoral level and even among patients with the same2
type of tumor. This situation can be a problem to use oxygen modulation therapies (2, 3), thus it would
be desirable to know  which tumors (patients) are sensitive to these treatments.a priori
Currently, there are several methods to measure hypoxia, but neither of them has been used in clinical
routine. In this sense, magnetic resonance imaging (MRI) techniques appear as interesting tools for
measuring pO  in vivo (4, 5). In this line, blood oxygen level dependent (BOLD) T2* weighted images2
are sensitive to blood oxygen level and blood flow. Recently, some studies have also shown the
possibility of assess tissue oxygenation level based on tissue oxygen level dependent (TOLD) T1
weighted images (2).
Our objective was to employ a new MRI methodology development to identify a priori those tumors
that could benefit from hyperoxic radiotherapy as treatment headed to oxygen tension modulation.
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2. Material and Methods
Animal model
High grade gliomas were induced in Wistar rats (200-220 g) by stereotaxic injection of C6 cells in the
right caudate nucleus. Experimental groups: 12 animals with tumors were studied, 6 were irradiated
while breathing pure oxygen (hyperoxia) and 6 while breathing air (normoxia). Treatment was
performed in a biologic irradiator (Shepherd Mark J-30 800 Ci 137Cs) using 10 Gy doses.
MRI studies
MRI acquisition were carried out in an horizontal 7T system (Bruker Pharmascan®) with a 1H selective
birdcage resonator of 38 mm. Animals were anesthetized with 2% isofluorane in oxygen, placed in a
heated probe and physiologically monitored.
To measure tumors volume T2W and Gd enhanced T1W images were acquired at different times after
cells injection. BOLD and TOLD contrast images were obtained the previous day to the treatment.
Series of interleaved TOLD (T1W) and BOLD (T2*W) images were acquired during transition from air
(baseline) to oxygen breathing.
Data analysis
MR images were analyzed with Image J (NIH, USA) software. Briefly, Signal Intensity (SI) in images
while breathing air was averaged and the percentage of change in SI (ΔSI%) when breathing oxygen
calculated for each time point during the process. The averaged ΔSI% when animal was breathing
oxygen was employed as the tumor total response (ΔSI% Total). Two regions of interest (ROI) were
studied, one in the tumor and other in the contralateral hemisphere. Tumor response was normalized
using the following equation:
Δ  (%) = [Δ  (% )  – Δ  (% )  ]/ Δ  (% )  x 100BOLD SI Total Tumor SI Total Contralateral SI Total Tumor
Therapy success was assessed by measuring the relative tumor volume at the end of the experiment
compared to the tumor size the day previous to the radiation.
3. Results
Figures 1 and 2 show how different tumors evolve with therapy. Tumors treated in normoxic
conditions (blue in figure 1 and top row in figure 2) stop growing immediately after irradiation but
after several days, they grow again. On the other hand, tumors treated in hyperoxic conditions (green
in figure 1 and bottom row in figure 2) decrease their tumor size. There are also tumor treated in
hyperoxic conditions that behave similarly to normoxic ones (red line in figure 1) but with a longer
stop in the growing.
Figure 1
Fig 1. Tumor size change with time after implantation. Red arrow indicates the day of radiation.
Blue line: normoxic conditions, red and green lines: hyperoxic conditions
Figure 2
Fig 2. T1W images with contrast agent at different times after tumor implantation. Top row shows
animal treated in normoxic conditions (tumor not responding). The bottom line represent an
animal irradiated while breathing oxygen (responsive tumor). Red arrow depicts the point when
tumors were treated.
Figure 3 shows an example of BOLD and TOLD responses in a single animal. Change in SI in BOLD is
approximately 15% in tumor and 2% in contralateral hemisphere (figure 3a). TOLD depicts changes in
SI about 6% in tumor and 3% in contralateral hemisphere (figure 3b).
Figure 3
Fig 3. Changes in SI in BOLD (a) and TOLD (b) images in response to transition from air to pure
oxygen in both tumor and in the contralateral hemisphere.
On the other hand, BOLD and TOLD responses are not dependent on tumor volume, as show in figure
4. Similar tumor volumes can depict completely different responses in BOLD and TOLD images.
Figure 4
Fig 4. Tumor size and average BOLD (a) and TOLD (b) tumor response relationship
We can establish that ΔBOLD response has not relation with the relative increase of growth volume
(figure 5a) at the end of the experiment. Nevertheless, ΔTOLD depict an inverse relationship with
tumor size at the end of the experiment (figure 5b). Tumors showing TOLD bigger than 40% respond
well to therapy whereas tumors depicting ΔTOLD smaller than 40% do not respond to therapy.
Figure 5
Fig 5. Relative tumor size (% of the tumor size the day before treatment in hyperoxic conditions) at
the end of the experiment based on their ΔBOLD (A) and ΔTOLD (B) response
To discard that the therapy efficacy would have predetermined because the tumor volume in the
radiation moment, we compared the relative volume growth at the end of the experiment with the
volume before therapy. Figure 6 clearly shows that there is no correlation between these 2
parameters.
Figure 6
Fig 6. Tumor relative volume at the end of the experiment vs tumor volume before irradiation
4. Conclusion
In this study, we propose a new MRI methodology as a tool that allows to predict which tumors would
benefit from a therapeutically method addressed to modulate oxygen tension in tumor tissue. This MR
approach is based on BOLD and TOLD contrast image acquisition. BOLD contrast is related with blood
oxygenation level, because it depends on the relation between oxyhemoglobin and
deoxyhemogobin. On the other hand, molecular oxygen (O ) has a pair of despaired electrons and it is2
going to behave as a contrast agent whose effects can be detected in MR T1 images. This is the
fundament of TOLD contrast and it is related with tissue oxygen level. To validate this methodology,
we chose a GBM murine model that presents a contrasted intertumoral heterogeneity.
Our main conclusions are:
1. BOLD and TOLD responses are independent from the tumor sized studied
2. In this glioblastoma rat model, tumor response to radiotherapy in hyperoxic conditions is not
determined by tumor volume
3. There is not correlation between BOLD response and therapy efficacy measured by relative tumor
size 18 days after irradiation, so this parameter does not predict which tumors would benefit from
hyperoxic radiotherapy
4. TOLD contrast yields a direct correlation between MR signal variation and response to radiotherapy
in hyperoxic conditions. Tumors with higher TOLD modulation had a better evolution due to the
treatment.
These results show the potentiality of TOLD MRI in predicting patients that could benefit from
treatments directed to modulate tumor tissue oxygen tension.
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